4672 related articles for article (PubMed ID: 16487455)
21. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity.
O'Meara S; Riemsma R; Shirran L; Mather L; ter Riet G
Health Technol Assess; 2001; 5(18):1-81. PubMed ID: 11399238
[TBL] [Abstract][Full Text] [Related]
22. Comparison of conference abstracts and full-text publications of randomized controlled trials presented at four consecutive World Congresses of Pain: Reporting quality and agreement of results.
Saric L; Vucic K; Dragicevic K; Vrdoljak M; Jakus D; Vuka I; Jelicic Kadic A; Saldanha IJ; Puljak L
Eur J Pain; 2019 Jan; 23(1):107-116. PubMed ID: 29987884
[TBL] [Abstract][Full Text] [Related]
23. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
[TBL] [Abstract][Full Text] [Related]
24. Interventions to promote technology adoption in firms: A systematic review.
Alfaro-Serrano D; Balantrapu T; Chaurey R; Goicoechea A; Verhoogen E
Campbell Syst Rev; 2021 Dec; 17(4):e1181. PubMed ID: 36950339
[TBL] [Abstract][Full Text] [Related]
25. TNF-alpha inhibitors for ankylosing spondylitis.
Maxwell LJ; Zochling J; Boonen A; Singh JA; Veras MM; Tanjong Ghogomu E; Benkhalti Jandu M; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2015 Apr; (4):CD005468. PubMed ID: 25887212
[TBL] [Abstract][Full Text] [Related]
26. An assessment of the impact of the NHS Health Technology Assessment Programme.
Hanney S; Buxton M; Green C; Coulson D; Raftery J
Health Technol Assess; 2007 Dec; 11(53):iii-iv, ix-xi, 1-180. PubMed ID: 18031652
[TBL] [Abstract][Full Text] [Related]
27. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
[TBL] [Abstract][Full Text] [Related]
28. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
29. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.
MacLehose RR; Reeves BC; Harvey IM; Sheldon TA; Russell IT; Black AM
Health Technol Assess; 2000; 4(34):1-154. PubMed ID: 11134917
[TBL] [Abstract][Full Text] [Related]
30. Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review.
Strech D; Soltmann B; Weikert B; Bauer M; Pfennig A
J Clin Psychiatry; 2011 Sep; 72(9):1214-21. PubMed ID: 21294992
[TBL] [Abstract][Full Text] [Related]
31. Transition from meeting abstract to full-length journal article for randomized controlled trials.
Toma M; McAlister FA; Bialy L; Adams D; Vandermeer B; Armstrong PW
JAMA; 2006 Mar; 295(11):1281-7. PubMed ID: 16537738
[TBL] [Abstract][Full Text] [Related]
32. Time to full publication of studies of anti-cancer medicines for breast cancer and the potential for publication bias: a short systematic review.
Takeda A; Loveman E; Harris P; Hartwell D; Welch K
Health Technol Assess; 2008 Oct; 12(32):iii, ix-x, 1-46. PubMed ID: 18831948
[TBL] [Abstract][Full Text] [Related]
33. Full publication of results initially presented in abstracts.
Scherer RW; Langenberg P; von Elm E
Cochrane Database Syst Rev; 2007 Apr; (2):MR000005. PubMed ID: 17443628
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis: Problems with Russian Publications.
Verbitskaya EV
Int J Risk Saf Med; 2015; 27 Suppl 1():S89-90. PubMed ID: 26639728
[TBL] [Abstract][Full Text] [Related]
35. Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.
Eddy K; Jordan Z; Stephenson M
JBI Database System Rev Implement Rep; 2016 Apr; 14(4):96-137. PubMed ID: 27532314
[TBL] [Abstract][Full Text] [Related]
36. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.
Claxton K; Palmer S; Longworth L; Bojke L; Griffin S; McKenna C; Soares M; Spackman E; Youn J
Health Technol Assess; 2012; 16(46):1-323. PubMed ID: 23177626
[TBL] [Abstract][Full Text] [Related]
37. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
38. [Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].
Amato L; Colais P; Davoli M; Ferroni E; Fusco D; Minozzi S; Moirano F; Sciattella P; Vecchi S; Ventura M; Perucci CA
Epidemiol Prev; 2013; 37(2-3 Suppl 2):1-100. PubMed ID: 23851286
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
